GSK2110183B Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Afuresertib is a selective, orally bioavailable inhibitor of Akt1, 2, and 3 with Ki values of 0.08, 2, and 2.6 nM, respectively. It preferentially inhibits the proliferation of human cancer cell lines with Akt pathway activation and various cell lines derived from hematologic malignancies with minimal effect on glucose homeostasis. Afuresertib demonstrates activity against multiple myeloma in both preclinical and clinical models.[Cayman Chemical]
GSK2110183B Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte